Gosta Labs
Category: AI in Healthcare
AI operating system for complex medical specialties, starting with oncology, that automates clinical documentation, structures patient data in real-time, and provides guideline-linked decision support Gosta Labs was founded in 2023. The company is led by Lauri Sippola. Based in Helsinki, Finland. Team size: 20-50. Total funding raised: €9.2 million. Latest round: Seed round. Key investors include Voima Ventures (lead), COR Group, Terveystalo, Aho family, Reaktor.
- Founded
- 2023
- Headquarters
- Helsinki, Finland
- Team size
- 20-50
- Total funding
- €9.2 million
Value proposition
Reduces administrative burden by automating documentation (cutting time by 2/3), improves care quality via AI-driven decision support, and tracks clinical parameters like Performance Status and CTCAE toxicity grades
Products and solutions
Gosta Aide (AI assistant for healthcare professionals), Gosta API (healthcare-specific models access), Gosta Life Sciences (clinical trials and real-world applications)
Unique value
Combines deep clinical domain expertise (ex-Elekta/Kaiku Health founders) with proprietary task-specific language models trained on oncology workflows, real-time structured data generation, and medical device-grade AI development
Target customer
Oncology professionals, healthcare providers, and complex medical specialty practitioners
Industries served
Healthcare Technology, Oncology, Medical Device Software, Clinical Decision Support Systems
Technology advantage
Medical-grade AI development, European regulatory infrastructure, partnerships with LUMI supercomputer for advanced model training, GDPR and EU AI Act compliance, IEC 62304 standard for SaMD development
How they differentiate
Gosta Labs differentiates through deep clinical domain expertise, medical-device-grade AI development, European regulatory infrastructure, proven deployment in complex oncology workflows, and leveraging longitudinal Nordic patient data for training, creating a 'Nordic Advantage' over US competitors
Main competitors
PathAI, RISA Labs, Nuance DAX, Abridge
Key partnerships
Voima Ventures (lead investor), COR Group (healthcare services partner), Reaktor (tech development collaboration), Terveystalo (healthcare provider network), LUMI Supercomputer (AI research partnership)
Notable customers
Leading healthcare providers in Finland, Switzerland, Baltics, and Australia, Coronaria, VARHA, Aarau TZ, LUVN, Läkärikeskus Aava, Terwe, Terveystalo
Major milestones
Launched AI operating system for oncology in 2023, Completed €7.5M oversubscribed seed round in November 2025, Achieved deployment in 4+ countries (Finland, Switzerland, Baltics, Australia), Built medical-device-grade AI platform with clinical integration, Presented real-world results at ESMO 2025 Congress
Growth metrics
Pre-revenue stage; documented 2/3 reduction in documentation time with median under 2 minutes for follow-up documentation; deployed across tens of thousands of clinical appointments
Market positioning
Positioned as a specialized AI operating system for complex medical specialties (primarily oncology), focusing on automating documentation and decision-support while maintaining regulatory compliance. Targets healthcare providers needing efficient, scalable AI solutions in regulated environments
Geographic focus
Europe (Finland, Switzerland, Baltics) with expansion into Australia and global markets. Strategic focus on European healthcare systems with plans to scale worldwide
Patents and IP
No publicly disclosed patents at this stage
About Lauri Sippola
Co-founder and former CEO of Kaiku Health (acquired by Elekta in 2020), VP Head of Business Development Comprehensive Oncology at Elekta, experienced in building and scaling regulated digital health solutions globally
Official website: https://www.gostalabs.com